---
figid: PMC4329195__12885_2015_1066_Fig1_HTML
figlink: /pmc/articles/PMC4329195/figure/Fig1/
number: F1
caption: The canonical activin pathway. Activin binds to activin type II receptors
  resulting in phosphorylation of the C terminus of Smad2 (pSmad2C) or smad3 followed
  by nuclear translocation with co-receptor Smad4. Follistatin binds to activin preventing
  binding the type II receptor. Phosphorylation at the linker region of Smad2 or smad3
  occurs downstream of cytoplasmic proteins such as RAS and nuclear proteins such
  as cyclin dependent kinases. The effector function of phosphorylated Smad2 is dependent
  on the site of phosphorylation; C terminus phosphorylation resulting in tumour growth
  suppression and linker phosphorylation resulting in tumour growth promotion.
pmcid: PMC4329195
papertitle: The differential anti-tumour effects of zoledronic acid in breast cancer
  â€“ evidence for a role of the activin signaling pathway.
reftext: Caroline Wilson, et al. BMC Cancer. 2015;15:55.
pmc_ranked_result_index: '33908'
pathway_score: 0.8768567
filename: 12885_2015_1066_Fig1_HTML.jpg
figtitle: Canonical activin pathway
year: '2015'
organisms:
- Homo sapiens
ndex: 46afab9b-dea1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4329195__12885_2015_1066_Fig1_HTML.html
  '@type': Dataset
  description: The canonical activin pathway. Activin binds to activin type II receptors
    resulting in phosphorylation of the C terminus of Smad2 (pSmad2C) or smad3 followed
    by nuclear translocation with co-receptor Smad4. Follistatin binds to activin
    preventing binding the type II receptor. Phosphorylation at the linker region
    of Smad2 or smad3 occurs downstream of cytoplasmic proteins such as RAS and nuclear
    proteins such as cyclin dependent kinases. The effector function of phosphorylated
    Smad2 is dependent on the site of phosphorylation; C terminus phosphorylation
    resulting in tumour growth suppression and linker phosphorylation resulting in
    tumour growth promotion.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - INHBB
  - SMAD4
  - SMAD3
  - SMAD2
  - SMAD1
  - INHBE
  - INHBA
  - SMAD5
  - SMAD7
  - SMAD9
  - SMAD6
genes:
- word: Activin
  symbol: Activin
  source: bioentities_symbol
  hgnc_symbol: INHBB
  entrez: '3625'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: Smad4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Smad3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: activin
  symbol: activin
  source: hgnc_alias_symbol
  hgnc_symbol: INHBE
  entrez: '83729'
- word: Smad2
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Activin
  symbol: Activin
  source: bioentities_symbol
  hgnc_symbol: INHBA
  entrez: '3624'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
chemicals: []
diseases: []
figid_alias: PMC4329195__F1
redirect_from: /figures/PMC4329195__F1
figtype: Figure
---
